Observational study / 2015
Elevated plasma TMAO was independently associated with an increased 5-year risk of death or heart transplantation in chronic systolic heart failure.
In 112 patients with chronic systolic heart failure, researchers measured plasma levels of TMAO and its dietary precursors, choline and betaine. Elevated levels of TMAO, choline, and betaine were each linked to higher NT-proBNP levels, advanced left ventricular diastolic dysfunction, and an increased risk of 5-year death/transplantation (TMAO HR 1.48; choline HR 1.64; betaine HR 1.51). After adjusting for age, eGFR, mitral E/septal Ea, and NT-proBNP, only higher TMAO remained an independent predictor of adverse clinical events (HR 1.46, 95% CI 1.03-2.14; P = .03).
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 112 patients with chronic systolic heart failure
- What was measured
- Echocardiographic indices and 5-year adverse clinical events (death/transplantation)
THE PAPER
Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH, Wang Z, Shrestha K, Borowski AG, Wu Y, Troughton RW, Klein AL, Hazen SL. J Card Fail, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.